Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population

Sexually Transmitted Infections

Volumn 75, Issue 2, 1999, Pages 98-102

  Kamali, A ^c   Nunn, A J ^d   Mulder, D W ^d   Van Dyck, E ^a   Dobbins, J G ^b   Whitworth, J A G ^d  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^d NONE

Author keywords

Genital ulcer infections; HIV 1; Rural population

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; FEMALE; GENITAL ULCER; HAEMOPHILUS DUCREYI; HUMAN; INCIDENCE; MALE; PRIORITY JOURNAL; RURAL AREA; SEROLOGY; SEROPREVALENCE; SEXUAL BEHAVIOR; TREPONEMA PALLIDUM; UGANDA;

EID: 0032962439     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.75.2.98     Document Type: Article

References (31)

1. 1 Mosha F, Nicoll L, Barongo M, et al. A population-based study of syphilis and sexually transmitted disease syndromes in north-western Tanzania. 1. Prevalence and incidence. Genitourin Med 1993;69:415-20.
2. 2 Grosskurth H, Mayaud F, Mosha F, et al. Asymptomatic gonorrhoea and chlamydial infection in rural Tanzanian men. BMJ 1996;312:277-80.
3. 3 Duncan ME, Roggen E, Tibaux G, et al. Seroepidemiological studies of Haemophilus ducreyi in Ethiopian women. Sex Transm Dis 1994;21:280-8.
4. 4 Le-Bacq F, Mason PR, Gwanzura L, et al. HIV and other sexually transmitted diseases at a rural hospital in Zimbabwe. Genitourin Med 1993;69:352-6.
5. 5 Beherts FM, Liomba G, Lule G, et al. Sexually transmitted diseases and human immunodeficiency virus control in Malawi: a field study of genital ulcer disease. J Infect Dis 1995;171:451-5.
6. 6 Hook EW, Cannon RO, Nahmias AJ, et al. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis 1992;165:251-5.
7. 7 Piot P, Van-Dyck E, Ryder RW, et al. Serum antibody to Haemophilus ducreyi as a risk factor for HIV infection in Africa, but not in Europe. International Conference on AIDS 1989 June 4-9;51 abstract no, MAO 32.
8. 8 Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993;7:95-102
9. 9 Nzila N, Laga M, Thiam MA, et al. HIV and other sexually transmitted diseases among female prostitutes in Kinshasa. AIDS 1991;5:715-21.
10. 10 Wagner HU, Van Dyck E, Roggen E, et al. Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population. Int J STD AIDS 1994;5:332-7.
11. 11 Nunn AJ, Mulder DW, Kamali A, et al. Mortality associated with HIV-1 infection over five years in a rural Ugandan population: cohort study. BMJ 1997;315:767-71.
12. 12 Nunn AJ, Wagner HU, Kamali A, et al. Migration and HIV-1 seroprevalence in a rural Ugandan population. AIDS 1995;9:503-6.
13. 13 Nunn AJ, Biryahwaho B, Downing R, et al. Algorithms for detecting antibodies to HIV-1: results from a rural Ugandan cohort. AIDS 1993;7:1057-61.
14. 14 Nunn AJ, Downing R, Biryahwaho B, et al. Computer-assisted quality assurance in an HIV-1 serology laboratory. Meth Inform Med 1994;33:170-3.
15. 15 Museyi K, Van Dyck E, Vervoort T, et al. Use of an enzyme immunoassay to detect serum IgG antibodies Haemophilus ducreyi. J Infect Dis 1988;157:1039-43.
16. 16 Sanchez-Martinez D, Schmid DS, Whittington W, et al. Evaluation of a test based on baculovirus-expressed glycoprotein G for detection of herpes simplex type-specific antibodies. J Infect Dis 1991;164:1196-9.
17. 17 Kengeya-Kayondo JF, Kamali A, Nunn AJ, et al. Incidence of HIV-1 infection in adults and socio-demographic characteristics of seroconverters in a rural population in Uganda: 1990-1994. Int J Epidemiol 1997;26:180-9.
18. 18 Desjardins M, Thompson CE, Filion LG, et al. Standardization of an enzyme immunoassay for human antibody to Haemophilus ducreyi. J Clin Microbiol 1992;30:2019-24.
19. 19 Pham-Kanter GBT, Steinberg RC, Ballard RC. Sexually transmitted diseases in South Africa. Genitourin Med 1996; 72:160-71.
20. 20 Grosskurth H, Mosha F, Todd J, et al. A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 2. Baseline survey results. AIDS 1995;9:927-34.
21. 21 Sewankambo N, Gray RH, Wawer M, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997;350:546-50.
22. 22 Killewo JZ, Sandstrom A, Bredberg-Raden U, et al. Prevalence and incidence of syphilis and its association with HIV-1 infection in a population-based study in the Kagera region of Tanzania. Int J STD AIDS 1994;5:424-31.
23. 23 Kreis J, Carael M, Meheus A. Role of sexually transmitted diseases in transmitting human immunodeficiency virus. Genitourin Med 1988;64:1-2.
24. 24 O'Farrell N, Tovey SJ. High cumulative incidence of genital herpes amongst HIV-1 seropositive heterosexuals in south London. Int J STD AIDS 1995;5:415-18.
25. 25 Augenbraun M, Feldman J, Chirgwin K, et al. Increased genital shedding of herpes simplex type 2 in HIV-seropositive women. Ann Intern Med 1995;123:845-7.
26. 26 Rawls WE, Adam E, Melnick JL. Geographical variation in the association of antibodies to herpesvirus type 2 and carcinoma of the cervix. In: Biggs Pm, de The G, Paynes LN, eds. Oncogenesis and herpesviruses. Scientific Publications II. Lyons: International Agency for Research on Cancer, 1972:424.
27. 27 Mertz GJ, Benedetti J, Ashley R, et al. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992;116:197-202.
28. 28 Bryson Y, Dillon M, Bernstein DI, et al. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis 1993;167:942-6.
29. 29 Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994;121:847-54.
30. 30 Whitley RJ, Kimberlin DW, Roizman B. Herpes simplex viruses. Clin Infect Dis 1998;26:541-55.
31. 31 Fleming DT, McQuuillan GM, Johnson KB, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-11.